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Summary 
Sympathetic neurons from perinatal rat pups extend 
only a single axon when maintained in culture in the 
absence of glia and serum. Exposure to recombinant 
osteogenic protein-1 (OP-1) selectively induces the 
formation of dendrites that correctly segregate and 
modify cytoskeletal and membrane proteins and form 
synaptic contacts of appropriate polarity. OP-1 re- 
quires nerve growth factor (NGF) as a cofactor, and, 
in the presence of optimal concentrations of NGF, OP- 
1-induced dendritic growth from cultured perinatal 
neurons is comparable to that observed in situ. Sym- 
pathetic neuroblasts that had not formed dendrites in 
situ also responded to OP-1 in culture, indicating that 
OP-1 can cause de novo formation as well as regenera- 
tion of dendrites. These data imply that specific sig- 
nals can regulate the development of neuronal shape 
and polarity. 
Introduction 
Dendrites are the primary site of synapse formation in the 
vertebrate nervous system, and neurons that lack den- 
drites typically receive fewer synaptic inputs than cells 
with complex dendritic arbors (Purves, 1988). Therefore, 
to understand how the number of afferent synapses is 
determined, it is necessary to identify the molecules that 
regulate the growth of dendrites. 
Dendritic growth can be considered to occur in two 
phases: initial extension followed by elongation and ramifi- 
cation. Many molecules, including neurotransmitters, hor- 
mones, and neurotrophic factors, have been shown to 
modulate the expansion of the dendritic arbor (Kelly, 1988; 
Mattson, 1988; Snider, 1988). Less is known about the 
factors that cause a neuron initially to form dendrites. Hip- 
pocampal neurons generate substantial dendritic arbors 
when they are cultured in the absence of their targets, of 
normal afferent input, and of contact with either glia or 
other hippocampal neurons (Dotti et al., 1988). These data 
suggest that, in certain classes of neurons, initial dendritic 
sprouting occurs as part of an intrinsic developmental pro- 
gram and that execution of this program is relatively inde- 
pendent of trophic interactions. However, the initial stages 
of dendritic growth appear to be regulated differently in 
other classes of neurons. For example, rat sympathetic 
neurons fail to form dendrites and extend only axons when 
they are cultured in the absence of nonneuronal cells. 
In contrast, coculture with Schwann cells or astrocytes 
causes these neurons also to form dendritic processes 
and eventually to generate an arbor that is comparable in 
size to that observed in situ (Tropea et al., 1988; Johnson 
et al., 1989). Since this change in cell shape is not ob- 
served with fibroblasts or heart cells, it would appear that 
specific trophic interactions are required to allow sympa- 
thetic neurons to form dendrites. 
Trophic regulation of the initial stages of de ndritic growth 
has also been observed in cultures of mesencephalic, stri- 
atal, cerebral cortical, and preganglionic sympathetic 
neurons (Denis-Donini et al., 1984; Chamak et al., 1987; 
Clendening and Hume, 1990; Le Roux and Reh, 1994), 
suggesting that it may be a fairly common mechanism 
for determining neuronal shape. However, little is known 
about the molecules that cause neurons to form dendrites. 
Indeed, the only trophic factor that has been clearly impli- 
cated in the regulation of the initial stages of dendritic 
growth is nerve growth factor (NGF). This growth factor 
causes a subpopulation of nodose neurons to form den- 
drites in culture (de Koninck et al., 1993). Because these 
neurons lack dendrites in situ, the physiological signifi- 
cance of this effect is unclear. The observation is, how- 
ever, consistent with the idea that there are trophic inter- 
actions that cause cells to form dendrites. NGF also 
enhances dendritic growth in sympathetic neurons when 
injected in situ (Snider, 1988). However, by itself, NGF 
does not support dendritic growth in cultures of sympa- 
thetic neurons (Bruckenstein and Higgins, 1988). It would 
therefore appear that there must be other molecules that 
regulate the morphological development of neurons. 
OP-1, which is also known as bone morphogenetic pro- 
tein-7 (BMP-7), is a member of the BMP/OP subfamily 
of the transforming growth factor I~ (TGFI3) superfamily 
(Sampath et al., 1992; Sampath and Rueger, 1994). Other 
members of this family include OP-2 (Ozkaynak et al., 
1992) and BMP-2 through BMP-6 (Wozney, 1993). Many 
of these proteins were discovered using assays that mea- 
sured de novo bone growth in vivo. However, there are 
indications that members of this subfamily also play a role 
in neural development. For example, mRNAs for OP-1, 
BMP-2, BMP-3, BMP-4, and BMP-5 have been detected 
in at least one region of the brain (Jones et al., 1991; 
Ozkaynak et al., 1992; Wozney, 1993), and immunocyto- 
chemical studies indicate that BMP-6 is prominently ex- 
pressed in most structures of the embryonic peripheral 
nervous system (Wall et al., 1993). Other studies indicate 
that OP-1 increases expression of the adrenergic pheno- 
type in neural crest cells (Varley et al., 1995) and regulates 
expression of L1 and neural cell adhesion molecule in a 
neural cell line (Perides et al., 1993), whereas BMP-2 and 
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BMP-6 affect the neurotransmitter phenotype of sympa- 
thetic neurons (Fann and Patterson, 1994). Moreover, a 
recently discovered member of the BMP/OP subfamily, 
dorsalin, was cloned from a spinal cord cDNA library and 
subsequently found to affect the differentiation of both 
neural crest cells and motor neurons (Basler et al., 1993). 
This study examines the effects of OP-1 on perinatal 
rat sympathetic neurons. Our data indicate that OP-1 spe- 
cifically induces dendritic growth in these cells, that it re- 
quires NGF as a cofactor, and that simultaneous exposure 
to both of these trophic factors causes the rate of expan- 
sion of the dendritic arbor in vitro to exceed that normally 
observed in situ. These observations uggest that, in addi- 
tion to known trophic interactions that affect the survival 
and neurotransmitter phenotype of sympathetic neurons 
(Thoenen and Barde, 1980; Patterson and Landis, 1992), 
there may be others that specifically regulate their mor- 
phological development. 
Results 
OP-1 Induces Dendritic Growth 
in Sympathetic Neurons 
Sympathetic neurons were dissociated from the superior 
cervical ganglia of perinatal rats. They were then plated 
onto polylysine-coated coverslips and maintained in a se- 
rum-free medium that contained NGF. Nonneuronal cells 
were eliminated by treatment with an antimitotic agent on 
days 2 and 3. One to 2 days were then allowed for recovery 
before beginning experimental treatments on day 5 or 6. 
Cellular morphology was initially assessed by intracellular 
dye injection. 
Under control conditions, sympathetic neurons typically 
extend a single process during the first 24-48 hr in vitro. 
Previous studies have shown that this process has the 
cytoskeletal and ultrastructural characteristics of an axon 
(Tropea et al., 1988; Lein and Higgins, 1989). The axon 
continues to elongate during the next few weeks and gen- 
erates an elaborate plexus (Figure 1). However, the basic 
morphology of the cells remains essentially unchanged 
(Figure 2), with 80% of the neurons still being unipolar 
after 1 month. Most of the remaining population had either 
2 axons (13% of the cells) or an axon and a short dendrite 
(7%). Thus, the mean number of processes at this time 
was 1.13 + 0.06 (n = 30)axons/cell and 0.07 _ 0.04 
dendrites/cell. 
Exposure to recombinant human OP-1 caused sympa- 
thetic neurons to form additional processes (see Figure 
1). The response was relatively slow, with only 42% of the 
cells forming a second process within 24 hr (see Figure 
2). However, virtually all cells responded to maximally ef- 
fective concentrations within 3 days. The processes that 
Figure 1. Effects of OP-1 on the Morphological Development ofSym- 
pathetic Neurons 
Phase-contrast (A and C) and fluorescence (B and D) micrographs of
neurons injected with Lucifer yellow during the third week in vitro. 
Neurons in control cultures (A and B) typically had only 1 process, a 
long axon. Neurons exposed to OP-1 (C and D) were multipolar, having 
several tapered dendrites and 1 axon. There was a tendency for the 
axons of OP-l-treated neurons to form small fascicles onpolylysine. 
However, this was not observed on other substrates, uch as laminin, 
which also supported OP-l-induced dendritic growth, suggesting that 
it is an epiphenomenon unrelated to the growth of dendrites. Bar, 
50 t~m. 
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Figure 2. Time Course of the Response to OP-1 
Sympathetic neurons were maintained in serum-free medium for 4 
days. Beginning on day 5 (arrows), the medium of some cultures was 
continuously supplemented with OP-1 (100 ng/ml). Intracellular dye 
injections (n > 30 per point) were performed at various times to deter- 
mine: (A) the percentage ofcells with dendrites (open symbols, control; 
closed symbols, OP-1); (B) the number of dendrites per cell; and (C) 
the number of axons per celt (circles). Cell number (triangles in [C]) 
remained constant during the experiment. Bars (B) represent the SEM; 
where bars are not shown, SEM was smaller than the size of the 
symbol. 
formed in the presence of OP-1 had the appearance of 
dendrites in that they were broad-based (up to 5 I~m in 
diameter), exhibited a distinct taper, and branched in a 
"Y"-shaped pattern, with daughter processes being signifi- 
cantly smaller than the parent process (see Figure 1). Den- 
drites were much thicker than axons, and unlike axons, 
they ended locally, usually extending less than 300 ~m 
from the soma. The number of dendrites per cell continued 
to increase during a 4 week exposure to OP-1, with most 
of the change occurring during the first 10 days of treat- 
ment (see Figure 2). After 4 weeks, OP-l-treated neurons 
had a mean of 7.3 _ 0.3 (n = 30) dendrites/cell, represent- 
ing an increase of - 100-fold over control cells. 
Exposure to OP-1 did not cause an increase in the num- 
ber of axons per cell when it was tested in the delayed 
introduction paradigm used in the experiment shown in 
Figure 2. We also examined the effects of OP-1 on initial 
axon growth during the first 48 hr in culture. Neither the 
rate at which axons were initially extended nor the mean 
number of axons per cell was affected (data not shown). 
It therefore appears that OP-1 affects sympathetic neu- 
rons in a process-specific manner. 
Cell number also remained constant during the expo- 
sure to OP-1 (see Figure 2), indicating that it was not acting 
by enhancing the survival of a subpopulation of neurons. 
However, the somata of neurons treated with OP-1 were 
larger than those of control cells (see Figure 1). The signifi- 
cance of this change is unclear, but since somatic hyper- 
trophy is also associated with sympathetic dendritic 
growth in situ (Voyvodic, 1987), it could simply reflect the 
added synthetic capacity needed to sustain the growth of 
additional processes. 
Proper t ies  of  Dendr i tes  Formed in the  Presence  
o f  OP-1  
When cultures exposed to OP-1 were immunostained with 
a monoclonal antibody (MAb) to microtubule-associated 
protein-2 (MAP2), immunoreactMty was observed in the 
somata and dendritic processes, but not in the thinner 
axons (Figure 3). Moreover, the mean number and aver- 
age length of the MAP2-positive processes corresponded 
closely (within 10%) to the values obtained from dye injec- 
tions, suggesting that all dendrites were stained in their 
entirety. A similar staining pattern was observed with 
MAbs to nonphosphorylated neurofilaments (Figure 3) and 
to the transferrin receptor (data not shown). In contrast, 
MAbs to tau (Figure 3), synaptophysin, or phosphorylated 
forms of the H or the M and H neurofilament subunits (data 
not shown) selectively stained the thin axons, with little or 
no immunoreactivity observed in the dendrites. 
When cultures treated with OP-1 were examined in the 
electron microscope, tapered dendrites were frequently 
observed emanating from neural somata. The dendritic 
cytoplasm was continuous with that of the soma, and proxi- 
mal dendrites contained both polyribosomes and occa- 
sional short segments of rough endoplasmic reticulum. 
Polyribosomes were also observed in more distal den- 
drites at distances greater than 100 p.m from the soma 
but were not observed in axons. In contrast, synaptic vesi- 
cles were seen only in axons. Dendrites were typically 
smoothly contoured and lacked the spinelike protrusions 
observed on some sympathetic neurons in situ (Matthews, 
1983). However, the synaptic contacts that were found 
along dendrites had an appropriate polarity; both presyn- 
aptic axonal accumulations of vesicles and postsynaptic 
densities were observed. 
Concent ra t ion -E f fec t  Re la t ionsh ip  and 
Compar i son  o f  OP-1  wi th  Other  Growth  Factors  
The effects of OP-1 were concentration dependent (Figure 
4A). Maximal dendritic growth was obtained with concen- 
trations between 30 and 100 ng/ml, and half-maximal ef- 
fects were observed at -2  ng/ml. However, significant 
changes in dendritic growth could be detected with con- 
centrations as low as 300 pg/ml. These data suggested 
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Figure 3. Cytochemical Characteristics of Processes Formed in the Presence of OP-1 
Phase-contrast (A) and fluorescence (B) micrographs of a neuron that was exposed to OP-1 for 18 days before being immunostained with a MAb 
(AP13) to MAP2. Immunoreactivity was observed primarily in the soma and dendrites, although there was occasional labeling of an axon (B, lower 
right). A similar staining pattern (C) was observed in cultures reacted with a MAb (SMI-32) to nonphosphorylated forms of the M and H neurofilament 
subunits (21 day exposure to OP-1). In contrast, prominent axonal labeling was observed in cultures reacted with a MAb to tau protein (D); an 
enlargement is shown i  (E). Label was also observed in the region of the cell body and dendrites, but confocal microscopy (1 ~m optical sections) 
revealed that i  was primarily associated with axons coursing over the surface of these structures (E). Bars, 50 ~m (B and C). 
a specific effect of the recombinant protein upon neurons, 
and this was confirmed by antibody blocking experiments. 
MAbs 1B12 and 12G3 have previously been shown (Vuki- 
cevic et al., 1994) to react with OP-1 but not with closely 
related molecules, such as BMP-2 and BMP-4. When 
added to the medium at a concentration of 5 ~g/ml, MAbs 
1 B12 and 12G3 inhibited OP-l- induced (2 ng/ml) dendritic 
growth by 71% and 100%, respectively. 
Since OP-1 belongs to the TGF~ superfamily, its actions 
were compared with those of other family members. Den- 
dritic growth was not observed in the presence of TGF~I, 
TGFI32, TGFI~3, activin A, inhibin, or gila-derived neuro- 
trophic factor (all tested at 100 ng/mi). Negative results 
were also obtained with similar concentrations of mem- 
bers of the neurotrophin (NT) family (NT3, NT4, and brain- 
derived neurotrophic factor), basic fibroblast growth fac- 
tor, epidermal growth factor, ciliary neurotrophic factor, 
leukemia inhibitory factor, hepatocyte growth factor, gran- 
ulocyte/macrophage colony-stimulating factor, F inter- 
feron, platelet-derived growth factor, TGFc~, vascular en- 
dothelial growth factor, and interleukin-113, -2, -3, -4, -6, 
-7, and -8. These data suggest that the dendrite-promoting 
effect of OP-1 is a specific response that is not observed 
with most of the other growth factors known to affect 
neurons. 
Effects of NGF on OP-l- lnduced Dendritic Growth 
NGF regulates the growth of sympathetic dendrites in situ 
(Snider, 1988), but dendritic growth was not observed in 
our control medium, which contained high levels of NGF. 
We therefore considered the hypothesis that NGF func- 
tions as a modulator rather than an inducer of dendritic 
growth. Neurons were exposed to a maximally effective 
concentration of OP-1 while the amount of NGF was var- 
ied. As the concentration of NGF was decreased from 100 
to 0.3 ng/ml (Figure 4B), there was a concentration- 
dependent decrease in the number of dendrites per cell 
and in the percentage of cells with dendrites. Cell number 
decreased over this same concentration range, and the 
half-maximal concentration for cell survival differed less 
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Figure 4. Effects of Varying Concentrations ofOP-1 and NGF on Den- 
dritic Growth 
(A) Sympathetic neurons were exposed to varying concentrations of
OP-1 for 3 days and then immunostained with a dendrite-specific anti- 
body (SMI-32) to determine the percentage of cells with dendrites 
(open circles) and the number of dendrites per cell (closed circles). 
Data are expressed as a percentage of the maximum value obtained 
in the presence of 100 ng/ml OP-1 (100% of the cells with dendrites; 
3.96 _+ 0.32 dendrites/cell). 
(B) Neurons were grown in media containing varying concentrations of 
NGF. Beginning on day 5, they were treated with a maximally effective 
concentration (100 ng/ml) of OP-1. One week later, they were immune- 
stained to determine the percentage of cells with dendrites (triangles; 
maximum value, 97O/o), the number of dendrites per cell (closed circles; 
maximum value, 4.7 _+ 0.3), and the number of neurons urviving per 
culture (open circles; maximum value, 2808 _+ 267). 
than 2-fold from that for either the percentage of cells with 
dendrites or the number of dendrites. These data suggest 
that NGF is a necessary cofactor for OP-l-induced den- 
dritic growth and that the amount of dendritic growth that 
occurs is critically dependent on the trophic state of the 
cell. 
A separate experiment directly examined the acute ef- 
fects of OP-1 on neuronal survival in the presence and 
absence of NGF. In control medium containing NGF (100 
ng/ml), 63% of the neurons plated survived for 48 hr under 
our low density culture conditions (9455 _+ 445 neurons/ 
22 mm well). A similar number (9641 _ 686 neurons/well) 
survived in the presence of both NGF and OP-1 (50 ng/ 
ml). In the absence of NGF, few neurons (62 _+ 25 neu- 
rons/well) survived, and this number was not signficantly 
increased in the presence of OP-1 (93 ± 74 neurons/well). 
Similar results were obtained with cultures of neurons from 
2-day-old pups (data not shown). In addition, OP-1 did not 
potentiate the effects of submaximal concentrations (0.1- 
30 ng/ml) of NGF on survival. Thus, the effects of OP-1 
are distinct from those of NGF, in that the former does 
not support neuronal survival. 
Comparison of Dendritic Growth In Vitro and In Situ 
To assess the potential importance of OP-1 as a regulatory 
molecule, we compared the amount of dendritic growth 
that occurs in vitro with that which normally occurs during 
a comparable period in situ (Table 1). For the former, we 
used cultures that had been exposed to optimal concentra- 
tions of OP-1 and NGF for 2 weeks. For the latter, we used 
published data (Snider, 1988) describing the dendritic mor- 
phology of superior cervical ganglion neurons in 2-week- 
old rat pups. Cells exposed to OP-1 in vitro were at least 
as complex as their counterparts in situ. They had about 
the same number of dendrites as cells in situ, but the 
length of their dendritic arbor was 38% greater. The in- 
crease in the size of the dendritic arbor in vitro seemed 
to be due primarily to increases in the radial length of 
dendrites because there was no detectable change in the 
amount of branching, as assessed by the method of Scholl 
(1953). Since these experiments were performed in a se- 
rum-free medium, it appears that a combination of only 
two trophic factors is a sufficient stimulus to allow the es- 
tablishment of a dendritic arbor of approximately normal 
dimensions. 
OP-1 Induces Dendritic Growth in Naive Neurons 
Many sympathetic neurons have formed rudimentary den- 
drites by the time of birth. Therefore, the previous experi- 
ments primarily reflect effects of OP-1 on dendritic regen- 
eration. To determine whether OP-1 could also promote 
de novo formation of these processes, we tested its effects 
on sympathetic neurons taken from 14.5 day embryos. At 
this time, there are still many neuroblasts in sympathetic 
ganglia (Hendry, 1977). 
Approximately half of the neurons from control and OP- 
1-treated cultures synthesized DNA (Table 2). Only a small 
subpopulation of control neurons formed dendrites; in con- 
trast, 95% of the neurons exposed to OP-1 formed such 
processes. Moreover, in OP-l-treated cultures, the num- 
ber of dendrites per neuron was similar in thymidine- 
labeled and unlabeled cells, suggesting that primitive neu- 
rons just exiting the cell cycle respond to OP-1 about as 
well as more mature postmitotic neurons. OP-l-treated 
cultures from 14.5 day embryos were examined by immu- 
nocytochemistry, and the pattern of staining was essen- 
tially identical to that observed in cultures from perinatal 
animals: the dendrites were selectively labeled with MAbs 
to MAP2 and nonphosphorylated forms of the M and H 
neurofilament subunits, while axons reacted with antibod- 
ies to tau, synaptophysin, and phosphorylated forms of 
the M and H neurofilament subunits. 
Discussion 
Our data indicate that OP-1 induces the formation of den- 
drites in sympathetic neurons, and that in the presence 
of an optimal concentration of NGF, the dendritic arbor 
expands at a rate at least equivalent o that observed dur- 
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Table 1. Comparison of the Dendritic Arbors Generated by Sympathetic Neurons In Situ and After a 2 Week Exposure to OP-1 
Parameter In Situ a In Vitro 
Number of dendrites/cell 6.9 ± 2.1 7.6 _ 0.4 
Total linear length of dendritic arbor (l~m) 779 _+ 288 1078 ± 77 
Maximum extent of arbor (l~m) 99 ± 31 171 ± 6 
Number of branches crossing 50% circle 8.0 ± 2.8 9.3 -+ 0.7 
Soma diameter (l~m) 29.2 ± 6.0 32.9 ± 0.5 
Cultures of sympathetic neurons were immunostained with MAb SMI-32 after a 2 week exposure to OP-1. Data are expressed as the mean ± 
SEM (n = 40). 
a In situ data are from Snider (1988). Mean ± SD. 
ing the first 2 postnatal weeks in situ. These observations 
suggest the existence of a novel type of trophic influence 
upon sympathetic neurons: one that affects cell shape 
without affecting survival. 
Some neural crest derivatives, such as sensory and 
many parasympathetic neurons, form only axons, whereas 
others, such as sympathetic neurons, also extend den- 
drites. The mechanisms that cause sympathetic neurons 
to diverge in shape have remained obscure. Our data indi- 
cate that sympathetic neurons form only axons when they 
are maintained in the presence of their target-derived sur- 
vival factor, NGF. Since cells grown under these condi- 
tions have previously been shown to have many properties 
expected of sympathetic neurons, such as appropriate 
electrical properties, receptors, and neurotransmitter phe- 
notype (Higgins et al., 1991), it appears that the extension 
of dendrites is not a constitutive part of the program for 
sympathetic differentiation. Rather, it seems to be a sub- 
routine whose expression is differentially regulated. In this 
respect, it is interesting to note that there has been an 
evolutionary change in the morphology of sympathetic 
neurons: amphibian sympathetic neurons are typically uni- 
polar while their mammalian counterparts usually have 
dendrites (Elfvin, 1983). 
Previous studies of sympathetic neurons suggested that 
the growth requirements of dendrites are more demanding 
than those of axons, with the former requiring molecules 
derived from sera, glia, or basement membranes (Tropea 
et al., 1988; Lein and Higgins, 1989). However, the poorly 
defined nature of these stimuli made it difficult to distin- 
guish specific effects on dendrites from nonspecific 
Table 2. OP-1 Induces Dendritic Growth in Sympathetic Neurons 
from 14.5 Day Embryos 
Nuclear Neurons wi th  Dendrites/ 
Condition Label Dendrites (%) Cell 
Control Yes (45%) 13 0.22 -*- 0.09 
No (55%) 7 0.09 _+ 0.05 
OP-1 Yes (52%) 96 4.62 _ 0.32 
No (48%) 94 4.06 ± 0.32 
Sympathetic ganglia from 14.5 day embryos were labeled for 18 hr 
with [3H]thymidine and then dissociated. After nonneuronal cells had 
been eliminated, some cultures were treated with OP-1 (100 ng/ml) 
for 12 days. Cultures were then immunostained with MAb SMI-32 and 
processed for autoradiography. Data are expressed as mean _+ SEM 
(n i> 100). 
changes in the health of neurons. The current data indicate 
that exposure to a recombinant growth factor induces den- 
dritic growth, and that this effect is blocked by MAbs that 
react with OP-1 but not with other closely related BMPs. 
The effects of OP-1 were observed in cultures grown in 
the absence of nonneuronal cells, indicating a direct effect 
upon neurons. Moreover, the structural requirements for 
inducing dendritic growth are quite stringent since this 
effect was not observed with 26 other growth factors, in- 
cluding members of the TGFI3 family. These observations 
strongly suggest that specific trophic interactions can reg- 
ulate the development of neuronal cell shape. 
Most of the sympathetic neurons that were obtained 
from perinatal pups had established rudimentary dendritic 
arbors in situ (Voyvodic, 1987). In contrast, -50% of the 
neurons taken from 14.5 day embryos were still synthesiz- 
ing DNA, and the others had just reached the stage where 
they were beginning to form dendrites in situ (Rubin, 1985). 
Yet virtually all of the neurons from these two groups 
formed dendrites in the presence of OP-I. These data 
suggest a potential morphogenetic role for OP-1 since it 
not only sustains dendritic regeneration but also promotes 
de novo synthesis in naive neurons. 
The dendrites formed in the presence of OP-1 were ap- 
propriate to sympathetic neurons in their shape, length, 
and number. They also exhibited appropriate functional 
specializations (Craig and Banker, 1994). Thus, these den- 
drites accumulate and postranslationally modify selected 
cytoskeletal and membrane proteins; exclude axonal pro- 
teins, transport ribosomes, and other types of RNA (un- 
published observations, P. L. and D. H.); and form synaptic 
contacts of correct polarity. The simplest explanation for 
these phenomena is that OP-1 induces the execution of 
a cellular program that controls both quantitative and quali- 
tative aspects of dendritic growth. Consistent with the no- 
tion of a program is the recent finding that nodose neurons, 
which normally do not form dendrites in situ, appropriately 
segregate cytoskeletal proteins when dendritic growth is 
induced in vitro (de Koninck et al., 1993). However, if this 
is the case, it is important to note that this does not appear 
to be an unrestricted program for dendritic growth, be- 
cause we never saw sympathetic cells with dendritic 
arbors that resembled those of pyramidal or Purkinje cells 
or with well-developed endritic spines. 
NGF regulates dendritic development in sympathetic 
neurons in situ (Snider, 1988; Ruit et al., 1990). A similar 
NGF dependence was noted in this study. In fact, in the 
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presence of optimal concentrations of NGF and OP-1, a 
dendritic arbor of normal dimensions was formed. Since 
our experiments were not performed at clonal density, one 
cannot rule out the involvement of intimate cell-cell  inter- 
actions, such as those mediated by cell adhesion mole- 
cules, in the development of dendrites in vitro. However, 
s ince the neurons were grown at low density in the ab- 
sence of nonneuronal cells, the data suggest that the num- 
ber of trophic substances that would have to be provided 
by other cell types, including targets, gila, and pregangli- 
onic fibers, is quite limited and that it could potentially 
consist of only two molecules. 
The relevance of this model to the regulation of dendritic 
growth in situ is still unclear. However, OP-1 mRNA or 
protein has been detected in most adult rat tissues that 
receive a sympathetic innervation, with particularly high 
levels being found in the kidney and in association with 
basement membranes (Ozkaynak et at., 1992; Wozney, 
1993; Vukicevic et al., 1994). OP-1 might therefore func- 
tion as a target-derived factor. Alternatively, the situation 
may be more complex, with local sources of dendrite- 
promoting molecules also being involved. OP-1 and 
BMP-6 are closely related homologs with greater than 
90% amino acid identity in the cysteine portion of the ma- 
ture protein. Wall et al. (1993) found that BMP-6 is present 
in high concentration in most parts of the embryonic pe- 
ripheral nervous system. In addition, Schluesener et al. 
(1995) have reported that adult rat Schwann cells express 
BMP-6, and our prel iminary data suggest that their embry- 
onic counterparts synthesize OP-1 (P. L. and D. H.). Thus, 
although the current data are limited, they suggest that 
sympathetic neurons may be exposed to dendrite- 
promoting BMPs both during development and in adult- 
hood. 
Trophic factors can affect many aspects of the develop- 
ment of sympathetic neurons, including their survival, 
rates of axonal growth, and neurotransmitter phenotype 
(Patterson and Nawa, 1993). The actions of OP-1 are dis- 
tinct from those of NGF (Thoenen and Barde, 1980) and 
NT3 (Birren et al., 1993) because OP-1 does not support 
neuronal survival. The effects of OP-1 are also different 
from those of extracellular matrix molecules such as lami- 
nin and col lagen IV, which selectively promote axonal 
elongation (Lein and Higgins, 1989; Lein et al., 1991) and 
which, in some cases, can also cause the formation of 
multiple axons. In contrast, OP-1 did not have detectable 
effects on either the initial extension of axons or the num- 
ber of axons per cell in long-term culture. The relationship 
between the regulation of neurotransmitter phenotype and 
morphological development is less clear. Molecules such 
as cholinergic differentiation factor/ leukemia inhibitory 
factor and ciliary neurot:ophic factor, which induce cholin- 
ergic function in sympathetic neurons (Patterson and Lan- 
dis, 1992), failed to promote dendritic growth, suggesting 
these developmental  processes can be regulated inde- 
pendently. On the other hand, the recent finding that 
BMP-2 and BMP-6 cause sympathetic neurons to express 
unique profiles of mRNAs for neuropeptides (Fann and 
Patterson, 1994) indicates that there could also be some 
overlap between the regulation of cell shape and neuro- 
transmitter phenotype. In either case, the data are consis- 
tent with a model in which multiple trophic interactions 
govern the expression of the complex assemblage of traits 
that comprise the sympathetic neuronal phenotype (Pat- 
terson and Nawa, 1993). The data also indicate that mem- 
bers of the BMP/OP family can exert profound and unique 
effects on the development of autonomic neurons. Such 
actions are consistent with their well-established role as 
differentiation factors in other systems, especial ly mesen- 
chymal tissues (Wozney, 1993). 
Experimental Procedures 
Materials 
Mature human recombinant OP-1 was isolated from medium condi- 
tioned by transfected Chinese hamster ovary cells using S-Sepharose 
and phenyI-Sepharose chromatography followed by reverse phase 
high performance liquid chromatography (Sampath et al., 1992). The 
purity was >98%, as assessed by SDS-polyacrylamide gel electropho- 
resis. Other growth factors were obtained from commercial sources: 
GIBCO/BRL (interleukin-t J~, -3, -4, -6, and -7; epidermal growth factor, 
basic fibroblast growth factor, granulocyte/macrophage colony- 
stimulating factor, leukemia inhibitory factor, TGFa, and rat F inter- 
feron); PeproTech, inc. (brain-derived neurotrophic factor, NT3, NT4, 
ciliary neurotrophic factor, and glial-derived neurotrophic factor); R&D 
Systems (-IGF~I, TGFI~2, TGF~3, and vascular endothelial growth 
factor); Collaborative Biomedical Products (hepatocyte growth factor, 
platelet-derived growth factor, and TGF~); Boehringer Mannheim (in- 
terleukin-2); and Promega (interleukin-8). MAbs (1B12 and 12G3; Cre- 
ative Biomolecules, Inc.) that react with OP-1, but not with BMP-2 or 
BMP-4, were affinity purified with Protein A agarose (Vukicevic et al., 
1994). 
Tissue Culture 
Suspensions of neurons dissociated from the superior cervical ganglia 
of Holtzman (Harlan Sprague-Dawley) rat fetuses (20-21 days) or rat 
pups (1-3 days postnatal) were prepared according to the method of 
Higgins et al. (1991). Equivalent results were obtained with pre~ and 
postnatal animals. Neurons were plated at low density ( -10 cells/ 
mm 2) onto poly-D-lysine-coated (100 ilg/ml) coverslips and maintained 
in a serum-free medium (Higgins et al., 1991) containing 13-NGF (100 
ng/ml) and three other proteins: bovine serum albumin (500 p.g/ml), 
bovine insulin (10 p.g/ml), and human transferrin (10 pg/ml). Equivalent 
results were obtained with NGF purified from mouse salivary glands 
(gift from E. M. Johnson) and recombinant human NGF (PeproTech, 
Inc.). Cytosine-~-b-arabinofuranoside (1 ~.M) was added to the medium 
of all cultures for 48 hr beginning on the second day; this exposure 
was usually sufficient o render them virtually free of nonneuronal cells 
for 30 days. 
To label sympathetic neuroblasts, ganglia from 14.5 day rat embryos 
were grown in explant culture for 18 hr in the presence of [methyl- 
3H]thymidine (0.3 p.Ci/ml; ICN Biomedicals, Inc.). Subsequently, the 
ganglia were exposed to trypsin, and the dissociated cells were plated 
on laminin-coated (10 ~.g/ml) coverslips (Higgins et al., 1991). Because 
NT3 (50 ng/ml) enhances the survival of immature sympathetic neu- 
rons (Birren et al., 1993), it was added to the NGF-containing medium 
during the period of explant culture and during the first 4 days of 
dissociated cell culture. 
Morphological Analyses 
Cellular morphology was routinely assessed by the intraceUular injec- 
tion of fluorescent dyes, Lucifer yellow (4%) or 5(6) carboxyfl uorescein 
(5%). Only neurons whose cell bodies were at least 150 ~m from other 
neuronal somata were injected because density-dependent changes 
in morphology occur when sympathetic neurons are separated by 
lesser distances (Bruckenstein and Higgins, 1988). 
Cultures were immunostained with antibodies previously shown to 
react selectively with either axons or dendrites (Sternberger and Ster- 
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nberger, 1983; Wiedenmann and Franke, 1985; Binder et al., 1986; 
Lein and Higgins, 1989; Cameron et al., 1991). MAbs to MAP2 (AP13 
and AP14; gift of L. I. Binder), to nonphosphorylated forms of the M 
and H neurofilament subunits (SMI-32; Sternberger-Meyer Immuno- 
cytochemicals), and to the transferrin receptor (MRC OX-26; Serotech) 
were used as dendritic markers. Axonal probes included MAbs to syn- 
aptophysin (SY-38; Boehringer Mannheim), tau (Taul; L. I. Binder), 
and phosphorylated forms of the H (NE14; Boehringer Mannheim) 
and the M and H (SMI-31 ; Sternberger-Meyer Immunocytochemicals) 
neurofilament subunits. All antigens were localized by indirect immu- 
nofluorescence using previously described procedures (Lein and Hig- 
gins, 1989). Image 1 Software (Universal Imaging) was used to quanti- 
tate dendritic growth in immunostained cultures. Maximum dendritic 
extent was determined by measuring the radius of a circle encom- 
passing the entire arbor. The number of branches crossing a circle 
of half that diameter was used as an index of branching (Schotl, 1953). 
Cultures were prepared for electron microscopy according to pub- 
lished procedures (Tropea et al., 1988). Data in the text are presented 
as mean - SEM. 
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